Trial | NCT00229216  Report issue

Title

Treatment of Bacterial Vaginosis With Oral Tinidazole
A Phase III Randomized, Multi-center, Double-blind, Double-dummy, Placebo-controlled Treatment Trial of Bacterial Vaginosis With Tinidazole Oral Tablets.

  • Phase

    Phase 3

  • Study Type

    Interventional

  • Status

    Completed No Results Posted

  • Intervention/Treatment

    tinidazole ...

  • Study Participants

    200
The purpose of this study is to confirm the safety and efficacy of oral tinidazole for the treatment of bacterial vaginosis.
Tinidazole is a second-generation nitroimidazole i.e. an updated form of the standard drug used to treat bacterial vaginosis (metronidazole). Two dosing regimens are being compared to placebo to treat bacterial vaginosis, one of the most common vaginal infections.
Study Started
Jan 31
2005
Primary Completion
Jun 30
2007
Study Completion
Jun 30
2007
Last Update
Mar 22
2017

Drug Tinidazole

Criteria 

Inclusion Criteria:

Clinical and microbiological diagnosis of bacterial vaginosis -

Exclusion Criteria:

Other sexually transmitted disease

-
No Results Posted